1 / 10

Academic-Industry Partnership Symposium Presented by: Blank Rome LLP

Academic-Industry Partnership Symposium Presented by: Blank Rome LLP.

alyssa
Download Presentation

Academic-Industry Partnership Symposium Presented by: Blank Rome LLP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Academic-Industry Partnership SymposiumPresented by: Blank Rome LLP

  2. The mission of PhIND is to create a collaborative research organization that attracts excellent scientists, accelerates the pace of research on neurodegenerative disorders, and establishes a leading, internationally-recognized center of Neuroscience discovery and development.

  3. Panel Members • Todd Abrams, PhD – BioStrategy Partners • Gordon Lutz, PhD – LifeSplice Pharma, LLC • Stephen Nappi – Temple University • David Gitlin, Esq. – Blank Rome LLP • Ezra Felker – Nupathe Inc. • John Reid, PhD, MBA – AstraZeneca

  4. Barriers to Collaboration

  5. Barriers to Collaboration

  6. Barriers to Collaboration

  7. New Models of Collaboration • “Drug discovery on campus” one to one industry to University relationships with a new purpose • Disease focus interest groups model (PhIND, Philly Derm) • Consortium Model • Regional technology exchange (Science Center – QED) • Example models: Coulter; MaRS District, CPATH New Barriers: New purpose of research; Complex agreements including financial, IP, operations and governance issues different from sponsored research

  8. New Models of Collaboration • Key points of Discussion: • Agreements some proprietary information such as compounds and targets not shared • Shared resource opportunities • Follow on research milestone based to reward success • Avoid IP argument by company having license to IP and data related to company compounds • Provisions to rewards academic innovation • Key to success: dedicated project and alliance management

  9. Q & AdfaThank you for your support!

  10. www.PhINDResearch.org

More Related